Statistics for Pfizer (id:8482 PFE)
Valuation metrics
Market cap
149.58B
Enterprise value
204.30B
Trailing P/E (ttm)
35.19
Forward P/E
9.01
PEG ratio
9.01
Price/Sales (ttm)
2.52
Price/Book (mrq)
1.62
Enterprise Value/Revenue
3.44
Enterprise Value/EBITDA
11.12
Overview
Shares outstanding
5.67B
Float
5.66B
Shares short
90.38M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
39.86M
Average volume (90 days)
Price summary
52-Week low
24.48
52-Week high
31.54
52-Week change
-7.78%
Beta
3.00
50-Day moving average
26.95
200-Day moving average
27.97
Dividends and splits
Forward annual dividend rate
1.68
Forward annual dividend yield
5.00
Trailing annual dividend rate
1.67%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
4.28
Payout ratio
2.23
Dividend date
March 7, 2025
Ex-dividend date
January 24, 2025
Last split factor
2:1
Last split date
November 17, 2020
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
7.16%
Operating margin
32.99%
Operational effectiveness
Return on assets
3.31%
Return on equity
4.54%
Income statement
Revenue (ttm)
10.49
Revenue per share (ttm)
10.49
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
33.54B
EBITDA
19.40B
Net income to common (ttm)
4.27B
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
31.20%
Balance sheet
Total cash (mrq)
9.95B
Total cash per share (mrq)
1.76
Total debt (mrq)
67.95B
Total Debt/Equity (mrq)
73.41
Current ratio (mrq)
100.00%
Book value per share (mrq)
16.29
Cash flow
Cash flow statement
11.26B
Levered free cash flow (LFCF)
11.42B